Publications

Publications

Publications

  • Mélanie Bédard, Jeannick O'Brien, Pierre O'Brien, Sébastien Fournier, Kevin Cormier and Gilles Robichaud, Pax-5B regulates B cell apoptosis through the modulation of cell fate components. En préparation
  • Mark Laflamme, Emmanuel Maïcas, Kevin Cormier, Mélanie Bédard, Pierre O'Brien, Rodney Ouellette and Gilles Robichaud, The Pax-5 oncogene and its alternatively spliced isoforms are overexpressed in breast cancer tissues. En préparation
  • Nicolas Crapoulet, Pierre O'Brien, Rodney Ouellette and Gilles Robichaud, Coordinated expression of Pax-5 and FAK1 in metastasis. Soumis à " Anti-Cancer Agents in Medicinal Chemistry", juin 2011.
  • Pierre O'Brien, Pier Morin, Rodney Ouellette and Gilles Robichaud, The Pax-5 gene: A pluripotent regulator of B cell differentiation and cancer disease. Soumis à "Cancer Research", juin 2011.
  • Jérémie Doiron; Al Haliffa Soultan ; Ryan Richard; Mamadou M Touré; Nadia Picot; Rémi Richard; Miroslava Čuperlović-Culf; Gilles A Robichaud; Mohamed Touaibia,. Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors. European Journal of Medicinal Chemistry, Accepté Juin 2011
  • Luc H. Boudreau, Nadia Picot, Jérémie Doiron, Benoît Villebonnet, Marc E. Surette, Gilles A. Robichaud and Mohamed Touaïbia, Caffeoyl and cinnamoyl clusters with anti-inflammatory and anti-cancer effects. Synthesis and structure-activity relationship, New J. Chem., Aug. 2009, DOI: 10.1039/b907878a
  • Gilles.A. Robichaud, Jean-Pierre Perreault and Rodney Ouellette. Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element. Nucleic Acid Research, 2008; 36(14):4609-4620
  • Asif Mufti*, Michel Lévesque*, Gilles A. Robichaud*, and J-P. Perreault. Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme. Current Gene Therapy. 2007 June; 7(3):205-216.
  • Mark Laflamme* and Gilles A. Robichaud* Gene suppression technologies in high-throughput analysis: front- and back-side applications. OMICS. 2007; 11(2):129-142.
  • Gilles A. Robichaud, Michel Nardini, Mark Laflamme, Mira Cuperlovic-Culf, Rodney J. Ouellette. Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. Journal of Biological Chemistry; 2004, 279(48):49956-49963
  • Mira Culf, Gilles A. Robichaud, Michel Nardini and Rodney Ouellette. Investigation of interaction between Pax-5 isoforms and thioredoxin using de novo modeling methods. In Silico Biology; 2003, 3(38):453-469.
  • Carle Ryckman*, Gilles A. Robichaud*, Jocelin Roy*, Réjean Cantin, Michel J. Tremblay and Philippe A. Tessier. HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. Journal of Immunology; 2002, 169(6):3307-3313.
  • Gilles A. Robichaud, Benoit Barbeau, Jean-Francois Fortin, and Michel J. Tremblay. NFAT is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. Journal of Biological Chemistry; 2002; 277(26):23733-23741
  • Benoit Barbeau*, Gilles A. Robichaud*, Jean-Francois Fortin and Michel J. Tremblay. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation. Journal of Immunology; 2001; 167(5):2700-2713.
  • Jean-Francois Fortin, Benoit Barbeau, Gilles A. Robichaud, Marie-Eve Paré, Anne-Marie Lemieux and Michel J. Tremblay. Regulation of NFAT by phosphotyrosyl-specific phosphatase activity: A positive effect on HIV-1 LTR-driven transcription and a possible implication of SHP-1. Blood; 2001, 97(8): 2390-2400
  • Gilles A. Robichaud and Louise Poulin. The HIV-1 Nef gene inhibits TNF-a-induced apoptosis and promotes cell proliferation through the action of MAPK and related kinases in human glial cells. AIDS Research and Human Retroviruses; 2000, 16(18): 1959-1965
  • Gilles A. Robichaud*, Nicolas Genois* and Michel J. Tremblay. Mono Mac 1: A New in vitro Model System to Study HIV-1 Infection in human cells of the mononuclear phagocyte series. Journal of Leukocyte Biology; 2000, 68: 854-864.
  • Jean-François Fortin, Benoit Barbeau, Gilles A. Robichaud and Michel J. Tremblay. T cell activation and regulation of HIV-1: Same effectors with distinct outcomes. Canadian Journal of Infectious Diseases; 1999, 10: 25-32
  • Alain Richard,* Gilles A. Robichaud*, Réjean Lapointe, Sylvain Bourgoin, André Darveau and Louise Poulin. Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumor necrosis factor-alpha in human glial cells. AIDS; 1997, 11:F1-F7

* indique une contribution équitable des auteurs à la réalisation

3 juin 2011